Werewolf Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell HOWL and other ETFs, options, and stocks.About HOWL
Werewolf Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of therapeutics engineered to stimulate the body’s immune system for the treatment of cancer. The firm offers Predator Technology which focuses on immune targeting and activation.
CEODaniel J. Hicklin
CEODaniel J. Hicklin
Employees46
Employees46
HeadquartersWatertown, Massachusetts
HeadquartersWatertown, Massachusetts
Founded2017
Founded2017
Employees46
Employees46
HOWL Key Statistics
Market cap52.18M
Market cap52.18M
Price-Earnings ratio-0.67
Price-Earnings ratio-0.67
Dividend yield—
Dividend yield—
Average volume430.72K
Average volume430.72K
High today$1.17
High today$1.17
Low today$1.02
Low today$1.02
Open price$1.02
Open price$1.02
Volume269.36K
Volume269.36K
52 Week high$2.38
52 Week high$2.38
52 Week low$0.595
52 Week low$0.595
Stock Snapshot
The current Werewolf Therapeutics(HOWL) stock price is $1.16, with a market capitalization of 52.18M. The stock trades at a price-to-earnings (P/E) ratio of -0.67.
On 2025-12-17, Werewolf Therapeutics(HOWL) stock moved within a range of $1.02 to $1.17. With shares now at $1.16, the stock is trading +13.9% above its intraday low and -0.4% below the session's peak.
Trading activity shows a volume of 269.36K, compared to an average daily volume of 430.72K.
The stock's 52-week range extends from a low of $0.60 to a high of $2.38.
The stock's 52-week range extends from a low of $0.60 to a high of $2.38.
People also own
Based on the portfolios of people who own HOWL. This list is generated using Robinhood data, and it’s not a recommendation.